147 related articles for article (PubMed ID: 20709632)
1. Cyclooxygenase-independent inhibitory effects on T cell activation of novel 4,5-dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors.
Iñiguez MA; Punzón C; Cacheiro-Llaguno C; Díaz-Muñoz MD; Duque J; Cuberes R; Alvarez I; Andrés EM; Buxens J; Buschmann H; Vela JM; Fresno M
Int Immunopharmacol; 2010 Oct; 10(10):1295-304. PubMed ID: 20709632
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
Márquez N; Sancho R; Macho A; Calzado MA; Fiebich BL; Muñoz E
J Pharmacol Exp Ther; 2004 Mar; 308(3):993-1001. PubMed ID: 14617683
[TBL] [Abstract][Full Text] [Related]
3. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors.
Iñiguez MA; Punzón C; Fresno M
J Immunol; 1999 Jul; 163(1):111-9. PubMed ID: 10384106
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation.
Takada Y; Bhardwaj A; Potdar P; Aggarwal BB
Oncogene; 2004 Dec; 23(57):9247-58. PubMed ID: 15489888
[TBL] [Abstract][Full Text] [Related]
5. Pseudoephedrine inhibits T-cell activation by targeting NF-κB, NFAT and AP-1 signaling pathways.
Fiebich BL; Collado JA; Stratz C; Valina C; Hochholzer W; Muñoz E; Bellido LM
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):98-106. PubMed ID: 21631396
[TBL] [Abstract][Full Text] [Related]
6. Induction of cyclooxygenase-2 expression by allergens in lymphocytes from allergic patients.
Chacón P; Vega A; Monteseirín J; El Bekay R; Alba G; Pérez-Formoso JL; Msartínez A; Asturias JA; Pérez-Cano R; Sobrino F; Conde J
Eur J Immunol; 2005 Aug; 35(8):2313-24. PubMed ID: 15997464
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory activities of ent-16alphaH,17-hydroxy-kauran-19-oic acid isolated from the roots of Siegesbeckia pubescens are due to the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB inactivation.
Park HJ; Kim IT; Won JH; Jeong SH; Park EY; Nam JH; Choi J; Lee KT
Eur J Pharmacol; 2007 Mar; 558(1-3):185-93. PubMed ID: 17207792
[TBL] [Abstract][Full Text] [Related]
9. Iodinated N-acylvanillamines: potential "multiple-target" anti-inflammatory agents acting via the inhibition of t-cell activation and antagonism at vanilloid TRPV1 channels.
Márquez N; De Petrocellis L; Caballero FJ; Macho A; Schiano-Moriello A; Minassi A; Appendino G; Muñoz E; Di Marzo V
Mol Pharmacol; 2006 Apr; 69(4):1373-82. PubMed ID: 16394182
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
[TBL] [Abstract][Full Text] [Related]
11. In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors.
Punzón C; Alcaide A; Fresno M
Int Immunopharmacol; 2003 Sep; 3(9):1293-9. PubMed ID: 12890427
[TBL] [Abstract][Full Text] [Related]
12. Imperatorin inhibits T-cell proliferation by targeting the transcription factor NFAT.
Márquez N; Sancho R; Ballero M; Bremner P; Appendino G; Fiebich BL; Heinrich M; Muñoz E
Planta Med; 2004 Nov; 70(11):1016-21. PubMed ID: 15549655
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.
Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS
Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation.
Wong VK; Zhou H; Cheung SS; Li T; Liu L
J Cell Biochem; 2009 May; 107(2):303-15. PubMed ID: 19301261
[TBL] [Abstract][Full Text] [Related]
15. Acetate inhibits NFAT activation in T cells via importin beta1 interference.
Ishiguro K; Ando T; Maeda O; Ohmiya N; Niwa Y; Goto H
Eur J Immunol; 2007 Aug; 37(8):2309-16. PubMed ID: 17615583
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-kappaB pathway.
Sarkar D; Saha P; Gamre S; Bhattacharjee S; Hariharan C; Ganguly S; Sen R; Mandal G; Chattopadhyay S; Majumdar S; Chatterjee M
Int Immunopharmacol; 2008 Sep; 8(9):1264-71. PubMed ID: 18602073
[TBL] [Abstract][Full Text] [Related]
17. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
Jimenez JL; Punzón C; Navarro J; Muñoz-Fernández MA; Fresno M
J Pharmacol Exp Ther; 2001 Nov; 299(2):753-9. PubMed ID: 11602691
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of lucidone in mice via inhibition of NF-kappaB/MAP kinase pathway.
Senthil Kumar KJ; Hsieh HW; Wang SY
Int Immunopharmacol; 2010 Apr; 10(4):385-92. PubMed ID: 20079881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
